Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Dapagliflozin
Dapagliflozin
Farxiga Meets One Primary Endpoint in Large Ph III Cardiovascular Outcomes Trial in 17,000 Patients with Type 2 Diabetes
CP Wire
Mon, 09/24/18 - 10:01 am
AstraZeneca
Farxiga
Dapagliflozin
clinical trials
type 2 diabetes
cardiovascular disease
AstraZeneca diabetes drug combination faces delay after FDA rebuff
Yahoo/Reuters
Fri, 10/16/15 - 06:58 am
AstraZeneca
diabetes
FDA
saxagliptin
Dapagliflozin
Bristol-AstraZeneca Diabetes Drug Wins U.S. FDA Approval
Bloomberg
Wed, 01/8/14 - 04:20 pm
Dapagliflozin
FDA
Bristol-Myers Squibb
diabetes
AstraZeneca
Bristol, AstraZeneca withdraw diabetes drug in Germany, the day after it was endorsed by an FDA panel
Yahoo/Reuters
Fri, 12/13/13 - 10:43 am
Germany
diabetes
AstraZeneca
Dapagliflozin
Bristol-Myers Squibb
FDA panel backs Bristol diabetes drug after prior rejection
Yahoo/Reuters
Thu, 12/12/13 - 05:01 pm
FDA
advisory panels
Bristol-Myers Squibb
diabetes
Dapagliflozin
FDA staff cautious on AstraZeneca, Bristol diabetes drug
Yahoo/Reuters
Tue, 12/10/13 - 09:21 am
FDA
AstraZeneca
Bristol-Myers Squibb
Dapagliflozin
diabetes
AstraZeneca: A Positive Future Awaits This Company
Seeking Alpha
Tue, 11/26/13 - 04:48 pm
AstraZeneca
Bristol-Myers Squibb
Xigduo
diabetes
Dapagliflozin
Bristol-Myers, AstraZeneca diabetes drug delivers improvement for patients in late-stage study
Yahoo/AP
Tue, 09/24/13 - 10:13 am
Bristol-Myers Squibb
diabetes
AstraZeneca
Dapagliflozin
AstraZeneca, Bristol resubmit NDA for diabetes therapy dapagliflozin
Fierce Biotech
Thu, 07/25/13 - 11:16 am
diabetes
Dapagliflozin
Bristol-Myers Squibb
AstraZeneca
This Undervalued Pharma Is Ready To Move Higher
Motley Fool
Sat, 12/8/12 - 11:28 am
AstraZeneca
type 2 diabetes
Forixga
Dapagliflozin
AstraZeneca's Forxiga For Type 2 Diabetes Is A Potential Blockbuster
Seeking Alpha
Fri, 11/16/12 - 10:13 am
AstraZeneca
Forxiga
diabetes
Dapagliflozin
J&J Experimental Diabetes Drug Helps High-Risk Patients
Bloomberg
Tue, 10/2/12 - 10:05 am
diabetes
JNJ
canagliflozin
Dapagliflozin
Bristol-Myers Squibb
AstraZeneca
AstraZeneca Will Soar On 2 New Drugs In 2013
Seeking Alpha
Thu, 06/21/12 - 05:54 pm
AstraZeneca
Bristol-Myers Squibb
JNJ
Eli Lilly
AZD4547
Merck
Sanofi
Dapagliflozin
Bristol-Myers, AstraZeneca announce results from Phase lll dapagliflozin study
Yahoo/The Fly On The Wall
Sun, 06/10/12 - 11:16 am
Bristol-Myers Squibb
AstraZeneca
Dapagliflozin
type 2 diabetes
diabetes
19 Clinical Trials Aren't Enough
Motley Fool
Sat, 01/21/12 - 04:44 pm
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
diabetes
Bristol, AstraZeneca Diabetes Drug Fails to Win FDA Backing
Bloomberg
Thu, 01/19/12 - 10:38 am
AstraZeneca
FDA
Bristol-Myers Squibb
diabetes
Dapagliflozin
9 Biotech Companies With FDA Approval Decision Dates In Q1 2012
Seeking Alpha
Mon, 12/12/11 - 11:14 am
FDA
Fentanyl SL
INSYS Therapeutics
Dapagliflozin
Bristol-Myers Squibb
Prochieve
Columbia Laboratories
Discovery Labs
Surfaxin
NeurogesX
Qutenza
Curis
Roche
vismodegib
Chelsea Therapeutics
Northera
ONYX Pharmaceuticals
Carfilzomib
Bristol-Myers Presents Data
Yahoo/Zacks
Sat, 12/10/11 - 12:56 pm
Bristol-Myers Squibb
AstraZeneca
diabetes
Dapagliflozin
glimepiride
Merck
NovoNordisk
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Bristol Myers-AstraZeneca Diabetes Drug Delayed by U.S. FDA
Bloomberg
Wed, 10/26/11 - 06:12 pm
Bristol-Myers Squibb
diabetes
FDA
AstraZeneca
Dapagliflozin
Pages
1
2
3
next ›
last »